王春燕,龚艳君,刘兆平,李建平,洪涛,陈明,霍勇

• 1:北京大学第一医院心内科

摘要(Abstract)：

目的探讨g-I/eGFR比值与急诊冠脉介入治疗术后发生对比剂肾病(contrast induced nephropathy,CIN)风险之间的关系,旨在建立一种更简捷合理的预测方法,减少急诊冠脉介入术后CIN的发生。方法回顾性分析2009年1月至2011年3月在北京大学第一医院因急性ST段抬高心肌梗死(ST-segmentel evation myocardial infarction,STEMI)接受急诊冠状动脉介入治疗手术的患者130例,记录术前血肌酐水平、术中对比剂用量、术后48～72h血肌酐水平,计算g-I/eGFR比值及对比剂肾病发生情况。使用SPSS13.0软件对资料进行分析,应用Mann-Whitney U检验了解CIN与各因素间的关系,应用Binary Logistic回归分析对可能影响肾功能的诸多因素进行分析。结果 130例患者中,发生对比剂肾病25例,发生率为19.2%。CIN和非CIN患者在术前及术后血肌酐、g-I/eGFR比值、使用主动脉内球囊反搏方面的差异具有统计学意义。基础肾病、Killip分级>I级、g-I/eGFR比值均与CIN的发生关系密切,其Exp(B)分别为7.742(95%CI0.932～64.301)、3.733(95%CI1.258～11.077)和0.031(95%CI0.002～0.557)。其中g-I/eGFR比值与CIN发生呈负相关(B=-3.476)。结论在急性STEMI行急诊PCI的患者中,基础肾病、心功能不全是CIN发生的危险因素,g-I/eGFR比值与CIN在本研究中呈负相关。

关键词(KeyWords)： 心肌梗死;血管成形术,经腔,经皮冠状动脉;肾病

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 王春燕,龚艳君,刘兆平,李建平,洪涛,陈明,霍勇

参考文献(References)：

• [1]Wang Y,Fu X,Wang X,et al.Protective effects of anisodamine on renal function in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.Tohoku J Exp Med,2011,224:91-97.
• [2]Marenzi G,Lauri G,Assanelli E,et al.Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction.J Am Coll Cardiol,2004,44:1780-1785.
• [3]McCullough PA,Adam A,Becker CR,et al.Epidemiology and prognostic implications of contrast-induced nephropathy.Am J Cardiol,2006,98(6A):5K-13K.
• [4]Kitajima K,Maeda T,Watanabe S,et al.Recent issues in contrast-induced nephropathy.Int J Urol,2011,18:686-690.
• [5]邹古明,颜红兵.对比剂肾病的诊断与治疗现状.中国介入心脏病学杂志,2005,13:194-196.
• [6]Gallagher S,Knight C.Contrast-induced nephropathy in primary percutaneous coronary intervention.Heart,2011,97:1723-1725.
• [7]Nyman U,Bjrk J,Aspelin P,et al.Contrast medium dose-to-GFR ratio:a measure of systemic exposure to predict contrast-induced nephropathy after percutaneous coronary intervention.Acta Radiol,2008,49:658-667.
• [8]Yoon HJ,Hur SH.Determination of safe contrast media dosage to estimated glomerular filtration rate ratios to avoid contrast-induced nephropathy after elective percutaneous coronary intervention.Korean Circ J,2011,41:265-271.
• [9]Ma YC,Zuo L,Chen JH,et al.Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease.J Am Soc Nephrol,2006,17:2937-2944.
• [10]Cavusoglu E,Chhabra S,Marmur JD,et al.The prevention of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention.Minerva Cardioangiol,2004,52:419-432.
• [11]Waybill MM,Waybill PN.Contrast media-induced nephrotoxicity:identification of patients at risk and algorithms for prevention.J Vasc Interv Radiol,2001,12:3-9.
• [12]Soma VR,Cavusoglu E,Vidhun R,et al.Contrast-associated nephropathy.Heart Dis,2002,4:372-379.
• [13]Hizoh I,Haller C.Radiocontrast-induced renal tubular cell apoptosis:hypertonic versus oxidative stress.Invest Radiol,2002,37:428-434.
• [14]Stacul F,van der Molen AJ,Reimer P,et al.Contrast induced nephropathy:updated ESUR Contrast Media Safety Committee guidelines.Eur Radiol,2011,21:2527-2541.
• [15]Richard S,Harold LD.Contrast-Induced Acute Kidney Injury.Circulation,2010,122:2451-2455.